81540 prior authorization | Blue Cross and Blue Shield of Montana
81540, Oncology (Tumor Of Unknown Origin) Mrna Gene Expression Profiling By Real-Time Rt- Pcr Of 92 Genes (87 Content And 5 Housekeeping) To Classify Tumor Into Main Cancer Type And Subtype Utilizing Formalin-Fixed Paraffin-Embedded Tissue Algorithm Reported As A Probability Of A Predicted Main Cancer Type And Subtype, is on the Blue Cross and Blue Shield of Montana commercial prior authorization list. Not a coverage or referral decision.
- Code
- 81540
- Description
- Oncology (Tumor Of Unknown Origin) Mrna Gene Expression Profiling By Real-Time Rt- Pcr Of 92 Genes (87 Content And 5 Housekeeping) To Classify Tumor Into Main Cancer Type And Subtype Utilizing Formalin-Fixed Paraffin-Embedded Tissue Algorithm Reported As A Probability Of A Predicted Main Cancer Type And Subtype
- Source
- 2026 Commercial Medical Surgical Prior Authorization Code List, Pg 155 Original policy